Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Nitric oxide charged catheters as a potential strategy for prevention of hospital acquired infections.

Margel D, Mizrahi M, Regev-Shoshani G, Ko M, Moshe M, Ozalvo R, Shavit-Grievink L, Baniel J, Kedar D, Yossepowitch O, Lifshitz D, Nadu A, Greenberg D, Av-Gay Y.

PLoS One. 2017 Apr 14;12(4):e0174443. doi: 10.1371/journal.pone.0174443. eCollection 2017.

2.

The very-high-risk prostate cancer: a contemporary update.

Mano R, Eastham J, Yossepowitch O.

Prostate Cancer Prostatic Dis. 2016 Dec;19(4):340-348. doi: 10.1038/pcan.2016.40. Epub 2016 Sep 13. Review.

3.

Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma.

Mandalapu RS, Remzi M, de Reijke TM, Margulis V, Palou J, Kapoor A, Yossepowitch O, Coleman J, Traxer O, Anderson JK, Catto J, de la Rosette J, O'Brien T, Zlotta A, Matin SF.

World J Urol. 2017 Mar;35(3):355-365. doi: 10.1007/s00345-016-1859-6. Epub 2016 May 27. Review.

4.
5.

Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study.

Margel D, Benjaminov O, Ozalvo R, Shavit Grievink L, Kedar I, Yerushalmi R, Ben-Aharon I, Neiman V, Yossepowitch O, Kedar D, Levy Z, Shohat M, Brenner B, Baniel J, Rosenbaum E.

BMC Cancer. 2014 Jul 21;14:528. doi: 10.1186/1471-2407-14-528.

6.

Lymphovascular invasion in testicular germ cell tumors: clinicopathological correlates.

Yossepowitch O, Ehrlich Y, Lubin M, Tal R, Konichezsky M, Baniel J.

Cent European J Urol. 2013;66(3):266-70. doi: 10.5173/ceju.2013.03.art5. Epub 2013 Nov 18.

7.

Predicting 15-year prostate cancer specific mortality after radical prostatectomy.

Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, Feng Z, Wood DP, Eastham JA, Yossepowitch O, Rabah DM, Kattan MW, Yu C, Klein EA, Stephenson AJ.

J Urol. 2011 Mar;185(3):869-75. doi: 10.1016/j.juro.2010.10.057. Epub 2011 Jan 15.

8.

Regarding: 'High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series'.

Eggener S, Gonzalgo M, Yossepowitch O.

Br J Cancer. 2009 Dec 15;101(12):2057-8; author reply 2059. doi: 10.1038/sj.bjc.6605455. No abstract available.

9.

Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.

Stephenson AJ, Kattan MW, Eastham JA, Bianco FJ Jr, Yossepowitch O, Vickers AJ, Klein EA, Wood DP, Scardino PT.

J Clin Oncol. 2009 Sep 10;27(26):4300-5. doi: 10.1200/JCO.2008.18.2501. Epub 2009 Jul 27.

10.

Effect of baseline glomerular filtration rate on survival in patients undergoing partial or radical nephrectomy for renal cortical tumors.

Pettus JA, Jang TL, Thompson RH, Yossepowitch O, Kagiwada M, Russo P.

Mayo Clin Proc. 2008 Oct;83(10):1101-6. doi: 10.4065/83.10.1101.

11.

Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma.

Eggener SE, Yossepowitch O, Kundu S, Motzer RJ, Russo P.

J Urol. 2008 Sep;180(3):873-8; discussion 878. doi: 10.1016/j.juro.2008.05.006. Epub 2008 Jul 17.

12.

Positive surgical margins at partial nephrectomy: predictors and oncological outcomes.

Yossepowitch O, Thompson RH, Leibovich BC, Eggener SE, Pettus JA, Kwon ED, Herr HW, Blute ML, Russo P.

J Urol. 2008 Jun;179(6):2158-63. doi: 10.1016/j.juro.2008.01.100.

13.

Low risk prostate cancer in men under age 65: the case for definitive treatment.

Jang TL, Yossepowitch O, Bianco FJ Jr, Scardino PT.

Urol Oncol. 2007 Nov-Dec;25(6):510-4. Review.

14.

Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy.

Yossepowitch O, Eggener SE, Serio AM, Carver BS, Bianco FJ Jr, Scardino PT, Eastham JA.

Eur Urol. 2008 May;53(5):950-9. Epub 2007 Oct 12.

15.

The natural history of noncastrate metastatic prostate cancer after radical prostatectomy.

Yossepowitch O, Bianco FJ Jr, Eggener SE, Eastham JA, Scher HI, Scardino PT.

Eur Urol. 2007 Apr;51(4):940-7; discussion 947-8. Epub 2006 Oct 30.

16.

Opisthorchiasis from imported raw fish.

Yossepowitch O, Gotesman T, Assous M, Marva E, Zimlichman R, Dan M.

Emerg Infect Dis. 2004 Dec;10(12):2122-6.

17.

Frequency of CHEK2*1100delC in New York breast cancer cases and controls.

Offit K, Pierce H, Kirchhoff T, Kolachana P, Rapaport B, Gregersen P, Johnson S, Yossepowitch O, Huang H, Satagopan J, Robson M, Scheuer L, Nafa K, Ellis N.

BMC Med Genet. 2003 Jan 15;4:1. Epub 2003 Jan 15.

18.

Sudden hearing loss following acute hepatitis.

Yossepowitch O, Lossos A, Lossos IS.

Postgrad Med J. 1999 May;75(883):309-12. No abstract available.

Supplemental Content

Loading ...
Support Center